Full Press Release Details
GERMANTOWN, Md. , Feb. 4, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN ), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari , PhD, President and CEO of Precigen, will participate in a virtual fireside chat at the Guggenheim Healthcare Talks Oncology Day on Friday, February 12, 2021 at 11:30 AM ET .
Participants may access the live webcast of the virtual event through Precigen's website in the Events & Presentations section at investors.precigen.com/events-presentations .
| Investor Contact: | Media Contact: | ||
| Steven Harasym | Glenn Silver | ||
| Vice President, Investor Relations | Lazar-FINN Partners | ||
| Tel: +1 (301) 556-9850 | [email protected] | ||
| [email protected] |
SOURCE Precigen, Inc.